Photo of Jann N Sarkaria

View Scopus Profile

Jann N Sarkaria, MD

  • 13099 Citations
  • 50 Scopus h-Index
1980 …2021
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1993 2019

  • 13099 Citations
  • 50 Scopus h-Index
  • 187 Article
  • 4 Review article
  • 1 Comment/debate
Filter
Comment/debate
2019

Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG) (Journal of Neuro-Oncology, (2019), 143, 3, (573-581), 10.1007/s11060-019-03194-z)

Jaeckle, K. A., Anderson, S. K., Twohy, E. L., Dixon, J. G., Giannini, C., Jenkins, R. B., Egorin, M. J., Sarkaria, J. N., Brown, P. D., Flynn, P. J., Schwerkoske, J., Buckner, J. C. & Galanis, E., Jul 1 2019, In : Journal of neuro-oncology. 143, 3, 1 p.

Research output: Contribution to journal › Comment/debate

Open Access
Oligodendroglioma
Astrocytoma
Names
Publications
Neoplasms